RANTES activation of phospholipase D in Jurkat T cells: Requirement of GTP-binding proteins ARF and RhoA

Journal of Immunology

Volumn 160, Issue 4, 1998, Pages 1894-1900

  Bacon, Kevin B ^a,b   Schall, Thomas J ^b   Dairaghi, Daniel J ^b  

^a NEUROCRINE BIOSCIENCES INC   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; BISINDOLYLMALEIMIDE; BREFELDIN A; EOTAXIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); IODINE 125; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE D; PHOSPHOLIPASE INHIBITOR; PROTEIN KINASE C INHIBITOR; RANTES;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; LEUKEMIA CELL LINE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ADP-RIBOSYLATION FACTORS; AMINO ACID SEQUENCE; BREFELDIN A; CYCLOPENTANES; DRUG SYNERGISM; ENZYME ACTIVATION; EPOXY COMPOUNDS; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; PHOSPHOLIPASE D; PROTEIN BINDING; PROTEIN KINASE C; RANTES; RHOA GTP-BINDING PROTEIN; SPIRO COMPOUNDS; T-LYMPHOCYTES;

EID: 0032519454     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Baggolini, M., B. Dewald, and B. Moser. 1994. Interleukin 8 and related chemotactic cytokines: C-X-C and C-C chemokines. Adv. Immunol. 55:97.
2. Bacon, K. B. 1997. Chemokines: therapeutic targets in inflammation and infectious disease. Drug News Perspect. 10:133.
3. Bacon, K. B., and T. J. Schall. 1996. Chemokines as mediators of allergic inflammation. Int. Arch. Allergy Appl. Immunol. 109:97.
4. 3C motif. Nature 385:640.
5. Kelner, G. S., J. Kennedy, K. B. Bacon, S. Kleyensteuber, D. A. Largaespada, N. A. Jenkins, N. G. Copeland, J. F. Bazan, K. W. Moore, T. J. Schall, and A. Zlotnik. 1994. Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395.
6. Kennedy, J., G. S. Kelner, S. Kleyensteuber T. J. Schall, M. C. Weiss, H. Yssel, P. V. Schnieder, B. G. Cocks, K. B. Bacon, and A. Zlotnik. 1995. Molecular cloning and functional characterization of human lymphotactin. J. Immunol. 155: 203.
7. Dilloo, D., K. Bacon, W. Holden, W. Zhong, S. Burdach, A. Zlotnik, and M. Brenner. 1996. Chemokine and cytokine gene transfer enhances anti-tumor activity. Nat. Med. 2:1090.
8. Loetscher, M., B. Gerber, P. Loetscher, S. A. Jones, L. Piali, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1996. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184:963.
9. Bluel, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, and T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HTV-1 entry. Nature 382:829.
10. Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J.-L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J.-M. Heard, I. Clark-Lewis, D. F. Legler, M. Loetscher, M. Baggiolini, and B. Moser. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833.
11. Murphy, P. M. 1996. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 7:47.
12. Samson, M., O. Labbe, C. Mollereau, C. Vassart, and M. Parmentier. 1996. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35:3362.
13. Combadier, C., S. K. Ahuja, H. L. Tiffany, and P. M. Murphy. 1996. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1α, MIP-1β and RANTES. J. Leukocyte Biol. 60:147.
14. Imai, T., M. Baba, M. Nishimura, M. Kakizaki, S. Tagaki, and O. Yoshie. 1997. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Immunol. 272:15063.
15. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269:1727.
16. Bacon, K. B., M. C. Szabo, H. Yssel, J. B. Bolen, and T. J. Schall. 1996. RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells. J. Exp. Med. 184:873.
17. Szabo, M. C., E. C. Butcher, B. McIntyre, T. J. Schall, and K. B. Bacon. 1997. Regulation of integrin expression and lymphocyte adhesion by the chemokine RANTES. Eur. J. Immunol. 27:1061.
18. Bacon, K. B., L. Flores-Romo, P. F. Life, D. D. Taub, B. A. Premack, S. J. Arkinstall, T. N. C. Wells, T. J. Schall, and C. A. Power. 1995. Interleukin-8-induced signal transduction in T lymphocytes involves receptor-mediated activation of phospholipases C and D. J. Immunol. 154:3654.
19. Billah, M. M., and J. C. Anthes. 1990. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem. J. 269:281.
20. Cook, S. J., and M. J. O. Wakelam. 1992. Phospholipases C and D in mitogenic signal transduction. Rev. Physiol. Biochem. Pharmacol. 119:13.
21. Roberts, M. F. 1996. Phospholipases: structural and functional motifs for working at an interface. FASEB J. 10:1159.
22. Hammond, S. M., Y. M. Altshuller, T.-C. Sung, S. A. Rudge, K. Rose, J. Engebrecht, A. J. Morris, and M. A. Frohman. 1995. Molecular characterization of a human ARF-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved family of genes. J. Biol. Chem. 270:29640.
23. Hammond, S. M., J. M. Jenco, S. Nakashima, K. Cadwallader, Q.-M. Gu, S. Cook, Y. Nozawa, G. D. Prestwich, M. A. Frohman, and A. J. Morris. 1997. Characterization of two alternatively spliced forms of phospholipase D1. J. Biol. Chem. 272:3860.
24. Malcolm, K. C., C. M. Elliott, and J. H. Exton. 1996. Evidence for Rho-mediated agonist stimulation of phospholipase D in Rat1 fibroblasts. J. Biol. Chem. 271: 13135.
25. Kuribara, H., K. Tago, T. Yokozeki, T. Sasaki, Y. Takai, N. Morii, S. Narumiya, T. Katada, and Y. Kanaho. 1995. Synergistic activation of rat brain phospholipase D by ADP-ribosylation factor and rhoA p21, and its inhibition by Clostridium botulinum C3 exoenzyme. J. Biol. Chem. 270:25667.
26. Pappan, K., W. Qin, J. H. Dyer, L. Zheng, and X. Wang. 1997. Molecular cloning and functional analysis of polyphosphoinositide-dependent phospholipase D, PLDβ, from Arabidopsis. J. Biol. Chem. 272:7055.
27. 2+-dependent phospholipase D with preference for phosphatidylserine and phosphatidylethanolamine in Saccharomyces cerevisiae. FEBS Lett. 393:236.
28. Pryer, N. K., L. J. Wuestehube, and R. Schekman. 1992. Vesicle-mediated protein sorting. Annu. Rev. Biochem. 61:471.
29. Boman, A. L., and R. A. Kahn. 1995. ARF proteins: the membrane traffick police? Trends Biochem. Sci. 20:147.
30. Frohman, M. A., and A. J. Morris. 1996. Phospholipid signalling: Rho is only ARF the story. Curr. Biol. 6:945.
31. De Camilli, P., S. D. Emr, P. S. McPherson, and P. Novick. 1996. Phosphoinositides as regulators of membrane traffick. Science 271:1533.
32. Pai, J.-K., E. A. Frank, C. Blood, and M. Chu. 1994. Novel ketoepoxides block phospholipase D activation and tumor cell invasion. Anticancer Drug Des. 9:363.
33. Kahn, R. A., P. Randazzo, T. Serafini, O. Weiss, C. Rulka, J. Clark, M. Amherdt, P. Roller, L. Orci, and J. E. Rothman. 1992. The amino terminus of ADP-ribosylation factor (ARF) is a critical determinant of ARF activities and is a potent and specific inhibitor of protein transport. J. Biol. Chem. 267:13039.
34. Anhert-Hilger, G., S. Bhakdi, and M. Gratzl. 1985. Minimal requirements for exocytosis: a study using PC12 cells permeabilized with staphylococcal α-toxin. J. Biol. Chem. 260:12730.
35. Bader, M.-F., D. Thierse, D. Aunis, G. Ahnert-Hilger, and M. Gratzl. 1986. Characterization of hormone and protein release from α-toxin-permeabilized chromaffin cells in primary culture. J. Biol. Chem. 261:5777.
36. ras upon T-cell activation. Nature 346:719.
37. Loetscher, P., M. Seitz, M. Baggiolini, and B. Moser. 1996. Interleukin 2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184:569.
38. Yang, S. F., S. Freer, and A. A. Benson. 1967. Transphosphatidylation by phospholipase D. J. Biol. Chem. 242:477.
39. Lippincott-Schwartz, J., L. Yuan, J. S. Bonifacino, and R. Klausner. 1989. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 56:801.
40. Lippincott-Schwartz, J., J.-G. Donaldson, A. Schweizer, E. G. Berger, H.-P. Huari, L. C. Yuan, and R. D. Klausner. 1990. Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell 60:821.
41. Aktories, K., U. Braun, S. Rosener, I. Just, and A. Hall. 1989. The rho gene product expressed in E. coli is a substrate of botulinum ADP-ribosyltransferase C3. Biochem. Biophys. Res. Commun. 158:209.
42. Aktories, K. J. 1997. Bacterial toxins that target Rho proteins. J. Clin. Invest. 99:827.
43. Liao, F., G. Alkhatib, K. W. C. Peden, G. Sharma, E. A. Berger, and J. M. Faber. 1997. STRL33, a novel chemokine receptor-like protein, functions as a fusion co-factor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185:2015.
44. Bednarek, S. Y., L. Orci, and R. Scheckman. 1996. Traffic COPs and the formation of vesicle coats. Trends Cell Biol. 6:468.
45. Malcolm, K. C., A. H. Ross, R.-G. Qui, M. Symons, and J. H. Exton. 1994. Activation of rat liver phospholipase D by the small GTP-binding protein RhoA. J. Biol. Chem. 269:25951.
46. Stewart, S. J., G. R. Cunningham, and F. S. House. 1993. Activation of phospholipase D following perturbation of the human T lymphocyte antigen receptor/ CD3 complex is dependent on protein kinase C. Cell. Signal. 5:315.
47. Martinson, E. A., I. Trilivas, and J. Heller-Brown. 1990. Rapid protein kinase C-dependent activation of phospholipase D leads to delayed 1,2-diglyceride accumulation. J. Biol. Chem. 265:22282.
48. Balboa, M. A., B. L. Firestein, C. Godson, K. S. Bell, and P. A. Insel. 1994. Protein kinase Ca mediates phospholipase D activation by nucleotides and phorbol ester in Madin-Darby canine kidney cells. J. Biol. Chem. 269:10511.
49. Conricode, K. M., K. A. Brewer, and J. H. Exton. 1992. Activation of phospholipase D by phospholipase C. J. Biol. Chem. 267:7199.
50. Ohguchi, K., Y. Banno, S. Nakashima, and Y. Nozawa. 1996. Regulation of membrane-bound phospholipase D by protein kinase C in HL60 cells. J. Biol. Chem. 271:4366.
51. Mullman, T. J., M. I. Siegel, R. W. Egan, and M. M. Billah. 1990. Complement C5a activation of phospholipase D in human neutrophils: a major route for the production of phosphatidates and diglycerides. J. Immunol. 144:1901.
52. Mollinedo, F., C. Gajate, and I. Flores. 1994. Involvement of phospholipase D in the activation of transcription factor AP-1 in human T lymphoid Jurkat cells. J. Immunol. 153:2457.
53. Craig, S. W., and R. P. Johnson. 1996. Assembly of focal adhesions: progress, paradigms, and portents. Curr. Opin. Cell Biol. 8:74.
54. Ktistakis, N. T., H. A. Brown, M. G. Waters, P. C. Sternweis, and M. G. Roth. 1996. Evidence that phospholipase D mediates ADP ribosylation factor-dependent formation of coated vesicles. J. Cell Biol. 134:295.